Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645690
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaChinese PLA General HospitalRecruitingEarly Phase 1
NCT07645690Recruiting
Early Phase 1
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Meta...Chinese PLA General Hospi...
NCT07644585
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and NeckIBA Proton Therapy, Inc.Not Yet RecruitingNot Applicable
NCT07644585Not Yet Recruiting
Not Applicable
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Ca...IBA Proton Therapy, Inc.
NCT07645768
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alternative to Conventional Posterior Double Plating in Extra-Articular Distal Shaft Humeral FracturesCairo UniversityActive Not RecruitingNot Applicable
NCT07645768Active Not Recruiting
Not Applicable
Is Anterior Reversed Proximal Humeral Locking Plate System (PHILOS) a Safe Alter...Cairo University
NCT07644741
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal PlayersFederal University of VicosaCompletedNot Applicable
NCT07644741Completed
Not Applicable
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal Pl...Federal University of Vic...
NCT07644403
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.Suzhou Immunofoco Biotechnology Co., LtdEnrolling By InvitationPhase 1
NCT07644403Enrolling By Invitation
Phase 1
Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid...Suzhou Immunofoco Biotech...
NCT07644832
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII DeficiencyShanghai RAAS Blood Products Co., Ltd.RecruitingPhase 1
NCT07644832Recruiting
Phase 1
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tol...Shanghai RAAS Blood Produ...
NCT07646535
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary AldosteronismShenzhen Salubris Pharmaceuticals Co., Ltd.Not Yet RecruitingPhase 2
NCT07646535Not Yet Recruiting
Phase 2
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses i...Shenzhen Salubris Pharmac...
NCT07644234
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic StrokeSichuan Provincial People's HospitalNot Yet RecruitingPhase 4
NCT07644234Not Yet Recruiting
Phase 4
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patie...Sichuan Provincial People...
NCT07644325
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament BiopsyClinique Saint Jean, FranceRecruitingNot Applicable
NCT07644325Recruiting
Not Applicable
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior C...Clinique Saint Jean, Fran...
NCT07646314
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techniques inPiriformis SyndromeRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646314Not Yet Recruiting
Not Applicable
Comparative Effects of Post-Isometric Relaxation and Reciprocal Inhibition Techn...Riphah International Univ...
NCT07645170
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of FaisalabadActive Not RecruitingNot Applicable
NCT07645170Active Not Recruiting
Not Applicable
Strain Counter-Strain vs Maitland Mobilization for Sacroiliac Joint PainUniversity of Faisalabad
NCT07644676
The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental RestorationsMalmö UniversityEnrolling By InvitationNot Applicable
NCT07644676Enrolling By Invitation
Not Applicable
The Impact of Adhesion Strategy on the Clinical Performance Of Indirect Dental R...Malmö University
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07645560
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic StrokeBeijing Tiantan HospitalNot Yet RecruitingPhase 2
NCT07645560Not Yet Recruiting
Phase 2
A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After...Beijing Tiantan Hospital
NCT07645079
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareSteno Diabetes Center CopenhagenNot Yet RecruitingNot Applicable
NCT07645079Not Yet Recruiting
Not Applicable
Automated Insulin Delivery Versus Daily Injections for Hospital Diabetes CareSteno Diabetes Center Cop...
NCT07646067
Closed Loop Glucose Control in a Simulated ICU SettingEmory UniversityNot Yet RecruitingNot Applicable
NCT07646067Not Yet Recruiting
Not Applicable
Closed Loop Glucose Control in a Simulated ICU SettingEmory University
NCT07644104
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang UniversityNot Yet RecruitingNot Applicable
NCT07644104Not Yet Recruiting
Not Applicable
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang University
NCT07645534
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.Valenta Pharm JSCRecruitingPhase 1
NCT07645534Recruiting
Phase 1
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta...Valenta Pharm JSC
Result Breakdown
Not yet recruiting8 (40%)
Recruiting6 (30%)
Active, not recruiting2 (10%)
Completed2 (10%)
Enrolling by invitation2 (10%)
not_applicable12 (60%)
Phase 13 (15%)
Phase 22 (10%)
Early Phase 11 (5%)
Phase 41 (5%)
Not Specified1 (5%)